7 results on '"Atrophy metabolism"'
Search Results
2. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
- Author
-
Mimuro M, Yoshida M, Miyao S, Harada T, Ishiguro K, and Hashizume Y
- Subjects
- Age of Onset, Atrophy metabolism, Atrophy pathology, Atrophy physiopathology, Autopsy, Brain metabolism, Brain physiopathology, Disease Progression, Fatal Outcome, Female, Frontotemporal Lobar Degeneration metabolism, Frontotemporal Lobar Degeneration physiopathology, Gliosis metabolism, Gliosis pathology, Gliosis physiopathology, Humans, Immunohistochemistry, Inclusion Bodies metabolism, Inclusion Bodies pathology, Middle Aged, Neuroglia metabolism, Neurons metabolism, Pick Disease of the Brain metabolism, Pick Disease of the Brain physiopathology, Tauopathies physiopathology, Brain pathology, Frontotemporal Lobar Degeneration pathology, Neuroglia pathology, Neurons pathology, Pick Disease of the Brain pathology, Tauopathies pathology
- Abstract
Frontotemporal lobar degeneration-tau, Pick's disease subtype (PiD) is one of the major types of frontotemporal dementia, but its pathogenesis and disease mechanisms remain unclear. Here, we report a case of very early PiD. The patient was a 63-year-old healthy woman without dementia or any apparent psychosis. She was admitted to the hospital with multiple organ failure, and died three days later. The brain weighed 1050g and showed focal atrophy of the parahippocampal gyrus and right medial temporal lobe. Microscopically, neuronal loss and gliosis were limited to the atrophic areas. Surprisingly, Pick bodies (PiBs) and ballooned neurons were abundant throughout the bilateral temporal cortices, including the dentate gyrus. Cortical lamination of PiBs was predominant in the upper layer (layer II>VI), and the size of early PiBs tended to be smaller than that in severely affected areas. Numerous glial tau-positive inclusions (astrocytic inclusions, oligodendroglial coiled bodies, and threads) were found not only in the cerebral cortex but also in the temporal white matter. The neuropathological findings in this case suggest that PiB formation started long before the appearance of clinical symptoms and that PiB formation originating from small neurons may differ from other tau aggregations such as neurofibrillary tangles.
- Published
- 2010
- Full Text
- View/download PDF
3. Activation of microglia/macrophages expressing phosphorylated S6 ribosomal protein in a case of hemimegalencephaly with progressive calcification and atrophy.
- Author
-
Nonoda Y, Saito Y, Itoh M, Nakagawa E, Sugai K, Takahashi A, Otsuki T, Saito Y, Arima K, Mizuguchi M, Goto Y, and Sasaki M
- Subjects
- Atrophy metabolism, Atrophy pathology, Atrophy physiopathology, Biomarkers analysis, Biomarkers metabolism, Brain physiopathology, Calcinosis metabolism, Calcinosis pathology, Calcinosis physiopathology, Cell Movement physiology, Child, Preschool, Encephalitis metabolism, Encephalitis pathology, Encephalitis physiopathology, Gliosis metabolism, Gliosis pathology, Gliosis physiopathology, Humans, Intracellular Signaling Peptides and Proteins metabolism, Macrophages metabolism, Male, Malformations of Cortical Development physiopathology, Phosphorylation, Protein Serine-Threonine Kinases metabolism, Ribosomal Protein S6 analysis, Ribosomal Protein S6 genetics, Signal Transduction physiology, TOR Serine-Threonine Kinases, Brain metabolism, Brain pathology, Malformations of Cortical Development metabolism, Malformations of Cortical Development pathology, Microglia metabolism, Ribosomal Protein S6 metabolism
- Abstract
A 3-year-old boy with right hemimegalencephaly (HME) showed massive calcification in the subcortical white matter and progressive atrophy of the affected hemisphere. Hemispherotomy was successful in amelioration of the patient's intractable epilepsy, and a surgical specimen from the epileptic focus was examined pathologically. Disarrangement of cortical layers along with dysmorphic appearance of neurons, balloon cells in the cortex and white matter, bi-layered calcifications in the superficial cortical layer and subcortical white matter, heterotopic neurons in the white matter, and diffuse astrogliosis were noted. Perivascular clustering of alpha-B-crystallin positive balloon cells was occasionally observed in the area of calcification. A diffuse increase was observed in the number of CD68-positive microglia/macrophages, particularly in perivascular and peri-calcification areas. These cells were often located within the calcification foci, which implicates their participation in the calcification process. Phosphorylated S6 ribosomal protein (P-S6) was expressed in large-sized neurons and numerous balloon cells, as well as in CD68-positive cells. In contrast, phosphorylated mammalian target of rapamycin (mTOR) was expressed in a small percentage of astrocytes, and phosphorylated p70S6 kinase was rarely identified in perivascular cells. These findings suggest that inflammatory processes have contributed to the pathogenesis of progressive calcification and atrophy in the megalencephalic hemisphere in this patient. Dissociation of expression of mTOR cascade components is common to other reported cases of HME, but P-S6 expression in microglia/macrophages has not been recognized. The cellular mechanism and significance of P-S6-specific activation of the mTOR cascade in HME, particularly in the inflammatory cell lineage, should be explored further.
- Published
- 2009
- Full Text
- View/download PDF
4. Acute encephalopathy with refractory status epilepticus: bilateral mesial temporal and claustral lesions, associated with a peripheral marker of oxidative DNA damage.
- Author
-
Shiihara T, Kato M, Ichiyama T, Takahashi Y, Tanuma N, Miyata R, and Hayasaka K
- Subjects
- 8-Hydroxy-2'-Deoxyguanosine, Acute Disease, Anticonvulsants therapeutic use, Atrophy metabolism, Atrophy pathology, Atrophy physiopathology, Basal Ganglia metabolism, Basal Ganglia pathology, Basal Ganglia physiopathology, Biomarkers blood, Biomarkers cerebrospinal fluid, Biomarkers urine, Brain metabolism, Brain physiopathology, Brain Diseases, Metabolic diagnosis, Brain Diseases, Metabolic metabolism, Bronchodilator Agents adverse effects, Child, Comorbidity, Deoxyguanosine blood, Deoxyguanosine cerebrospinal fluid, Deoxyguanosine urine, Female, Free Radicals blood, Free Radicals cerebrospinal fluid, Free Radicals urine, Humans, Magnetic Resonance Imaging, Status Epilepticus diagnosis, Status Epilepticus metabolism, Temporal Lobe metabolism, Temporal Lobe pathology, Temporal Lobe physiopathology, Theophylline adverse effects, Treatment Outcome, Up-Regulation physiology, Brain pathology, Brain Diseases, Metabolic physiopathology, DNA Damage physiology, Deoxyguanosine analogs & derivatives, Oxidative Stress physiology, Status Epilepticus physiopathology
- Abstract
We describe a 12-year-old girl, who had been medicated with theophylline for bronchial asthma and developed acute encephalopathy with refractory status epilepticus, showing bilateral mesial temporal and claustral lesions, which were evident on fluid-attenuated inversion recovery images, obtained with 1.5 T magnetic resonance imaging. To date, oxidative stress has been implicated in aging or various disorders, including inflammatory or degenerative neurological disorders. One of the oxidative stress markers, 8-hydroxydeoxyguanosine, was increased in our patient's cerebro-spinal fluid, plasma and urine. We speculate that augmented oxidative stress was associated with refractory status epilepticus in our patient, accompanying bilateral mesial temporal, claustral lesions and severe neuronal damage. Serial measurements of oxidative stress markers in acute encephalitis, encephalopathy, or status epilepticus could clarify the relationships between acute brain damage and free radicals.
- Published
- 2006
- Full Text
- View/download PDF
5. Antimyoclonic effect of levetiracetam in MERRF syndrome.
- Author
-
Mancuso M, Galli R, Pizzanelli C, Filosto M, Siciliano G, and Murri L
- Subjects
- Activities of Daily Living, Anticonvulsants therapeutic use, Atrophy genetics, Atrophy metabolism, Atrophy pathology, Brain metabolism, Brain pathology, Brain physiopathology, Drug Therapy, Combination, Female, Genetic Predisposition to Disease genetics, Humans, Levetiracetam, MERRF Syndrome genetics, MERRF Syndrome physiopathology, Middle Aged, Mitochondria drug effects, Mitochondria genetics, Mitochondria metabolism, Muscle, Skeletal metabolism, Muscle, Skeletal pathology, Muscle, Skeletal physiopathology, Mutation genetics, Myoclonus genetics, Myoclonus physiopathology, Phenylalanine genetics, Phenylalanine metabolism, Piracetam pharmacology, Piracetam therapeutic use, Quality of Life, RNA, Transfer genetics, Treatment Outcome, Ubiquinone therapeutic use, Valproic Acid adverse effects, Anticonvulsants pharmacology, MERRF Syndrome drug therapy, Myoclonus drug therapy, Piracetam analogs & derivatives
- Abstract
The treatment of progressive myoclonic epilepsy (PME) is largely empirical, even though valproic acid (VPA) is usually considered the drug of first choice. However, VPA should be used with caution in PME due to mitochondrial dysfunction, i.e. in MERRF (myoclonic epilepsy with ragged red fibers) syndrome, because of its interaction with mitochondrial respiration and metabolism. Levetiracetam (LEV) treatment was started in combination with VPA in a patient with typical clinical, histological, and biochemical features of MERRF due to a mutation on the tRNA of Phenilalanine gene. The average myoclonus score improved dramatically, as well as the quality of life and no side effects were observed, even after having withdrawn VPA. LEV may benefit myoclonus in PME of mitochondrial origin without altering mitochondrial function, and it could be considered the drug of first choice for the treatment of myoclonus in MERRF.
- Published
- 2006
- Full Text
- View/download PDF
6. Cytoskeleton abnormalities in axonopathies of unknown aetiology: correlations with morphometry.
- Author
-
Fressinaud C, Vigneron I, Letournel F, Nicolas G, Jean I, and Dubas F
- Subjects
- Adult, Aged, Atrophy metabolism, Atrophy pathology, Atrophy physiopathology, Axons pathology, Cell Count, Cytoskeleton pathology, Female, Humans, Immunohistochemistry, Male, Middle Aged, Nerve Degeneration pathology, Nerve Degeneration physiopathology, Nerve Fibers metabolism, Nerve Fibers pathology, Nerve Fibers, Myelinated metabolism, Nerve Fibers, Myelinated pathology, Neural Conduction physiology, Neurofilament Proteins metabolism, Peripheral Nerves pathology, Peripheral Nerves physiopathology, Peripheral Nervous System Diseases pathology, Peripheral Nervous System Diseases physiopathology, Tubulin metabolism, Axons metabolism, Cytoskeleton metabolism, Nerve Degeneration metabolism, Peripheral Nerves metabolism, Peripheral Nervous System Diseases metabolism
- Abstract
To determine if specific axonal cytoskeleton abnormalities could be demonstrated in axonopathies without aetiology, nerve biopsies from five controls and nine cases were analyzed by morphometry and immunocytochemistry with anti-neurofilament (NF, subunits L, M, H) and anti-beta tubulin (TUB) antibodies. Morphometry revealed either large fiber atrophy (decrease in large fiber density with increased density in small fibers), degeneration of large fibers (decrease in large fiber density and in total density of fibers) or of all diameter fibers. NF immunostaining density decreased (by 21-89%) only in cases with fiber loss, in parallel to myelinated fiber density as determined by morphometry. On the contrary, the density of fibers labelled for TUB increased significantly in all except two cases by 52-102% over controls. Nevertheless, in these two cases--with a severe loss of fibers--as well as in other cases, the ratio of the density of fibers labelled for TUB and NFL (TUB/NFL) increased by 48-404%. Thus, the total density of myelinated fibers was always inversely correlated with the TUB/NFL ratio. Similar abnormalities have been described only after axotomy; our cases could thus be compared to <
>. - Published
- 2002
- Full Text
- View/download PDF
7. Hereditary motor and sensory neuropathy associated with cerebellar atrophy (HMSNCA): a new disease.
- Author
-
Fukuhara N, Nakajima T, Sakajiri K, Matsubara N, and Fujita M
- Subjects
- Adult, Atrophy metabolism, Cerebellum metabolism, Charcot-Marie-Tooth Disease genetics, Charcot-Marie-Tooth Disease metabolism, Disease Progression, Evaluation Studies as Topic, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neural Conduction, Pedigree, Tomography, X-Ray Computed, Atrophy genetics, Cerebellum pathology, Charcot-Marie-Tooth Disease pathology
- Abstract
Seven patients with hereditary motor and sensory neuropathy associated with cerebellar atrophy (HMSNCA) are presented. This is the first comprehensive evaluation of what is a unique disorder, half way between the cerebellar atrophies and the hereditary motor and sensory neuropathies. In addition to cerebellar ataxia and peripheral neuropathy, the most frequent features in HMSNCA were nystagmus, dysarthria, mental impairment and tremor. Pyramidal signs or autonomic nerve dysfunction was never revealed. Scoliosis or kyphoscoliosis was not noted. Progression of the disorder was very slow, most of the patients being ambulatory more than 10 years after the onset. Most of the patients had hypoalbuminemia. Half-life periods of serum albumin were normal and decreased synthesis of albumin in the liver was suspected. An autosomal recessive inheritance was strongly suggested, because of healthy consanguineous parents and affected siblings in these families. The segregation ratio was 0.32 +/- 0.10 and was close to the expected ratio of 0.25 in an autosomal recessive inheritance.
- Published
- 1995
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.